Böhle A - Search Results

1

Optimizing syngeneic orthotopic murine bladder cancer (MB49).

Günther JH, Jurczok A, Wulf T, Brandau S, Deinert I, Jocham D, Böhle A. Günther JH, et al. Among authors: bohle a. Cancer Res. 1999 Jun 15;59(12):2834-7. Cancer Res. 1999. PMID: 10383142

2

The role of LFA-1 in the lysis of bladder cancer cells by bacillus Calmette-Guérin and interleukin 2-activated killer cells.

Suttmann H, Jocham D, Böhle A, Brandau S. Suttmann H, et al. Among authors: bohle a. Urol Res. 2002 Sep;30(4):233-9. doi: 10.1007/s00240-002-0268-z. Epub 2002 Jul 5. Urol Res. 2002. PMID: 12202941

3

Neutrophil granulocytes are required for effective Bacillus Calmette-Guérin immunotherapy of bladder cancer and orchestrate local immune responses.

Suttmann H, Riemensberger J, Bentien G, Schmaltz D, Stöckle M, Jocham D, Böhle A, Brandau S. Suttmann H, et al. Among authors: bohle a. Cancer Res. 2006 Aug 15;66(16):8250-7. doi: 10.1158/0008-5472.CAN-06-1416. Cancer Res. 2006. PMID: 16912205

4

Effects of acetylic salicylic acid and pentoxifylline on the efficacy of intravesical BCG therapy in orthotopic murine bladder cancer (MB49).

Günther JH, Frambach M, Deinert I, Brandau S, Jocham D, Böhle A. Günther JH, et al. Among authors: bohle a. J Urol. 1999 May;161(5):1702-6. J Urol. 1999. PMID: 10210443

5

NK cells are essential for effective BCG immunotherapy.

Brandau S, Riemensberger J, Jacobsen M, Kemp D, Zhao W, Zhao X, Jocham D, Ratliff TL, Böhle A. Brandau S, et al. Among authors: bohle a. Int J Cancer. 2001 Jun 1;92(5):697-702. doi: 10.1002/1097-0215(20010601)92:5<697::aid-ijc1245>3.0.co;2-z. Int J Cancer. 2001. PMID: 11340575

6

Activation of natural killer cells by Bacillus Calmette-Guérin.

Brandau S, Böhle A. Brandau S, et al. Among authors: bohle a. Eur Urol. 2001 May;39(5):518-24. doi: 10.1159/000052497. Eur Urol. 2001. PMID: 11464031

7

Inhibition of bladder carcinoma cell adhesion by oligopeptide combinations in vitro and in vivo.

Böhle A, Jurczok A, Ardelt P, Wulf T, Ulmer AJ, Jocham D, Brandau S. Böhle A, et al. J Urol. 2002 Jan;167(1):357-63. J Urol. 2002. PMID: 11743356

8

IFN-gamma and IL-12 but not IL-10 are required for local tumour surveillance in a syngeneic model of orthotopic bladder cancer.

Riemensberger J, Böhle A, Brandau S. Riemensberger J, et al. Among authors: bohle a. Clin Exp Immunol. 2002 Jan;127(1):20-6. doi: 10.1046/j.1365-2249.2002.01734.x. Clin Exp Immunol. 2002. PMID: 11882028 Free PMC article.

9

Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity.

Böhle A, Jocham D, Bock PR. Böhle A, et al. J Urol. 2003 Jan;169(1):90-5. doi: 10.1016/S0022-5347(05)64043-8. J Urol. 2003. PMID: 12478111

10

Antisense treatment against Ki-67 mRNA inhibits proliferation and tumor growth in vitro and in vivo.

Kausch I, Lingnau A, Endl E, Sellmann K, Deinert I, Ratliff TL, Jocham D, Sczakiel G, Gerdes J, Böhle A. Kausch I, et al. Among authors: bohle a. Int J Cancer. 2003 Jul 10;105(5):710-6. doi: 10.1002/ijc.11111. Int J Cancer. 2003. PMID: 12740923

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

365 results

Search Page

Filters